Version: 1.0.0 | Published: 8 Oct 2024 | Updated: 228 days ago
Documentation
Associated Media:
https://www.youtube.com/watch?v=ZK9-Jw3uVkw
https://www.hdruk.ac.uk/news/covid-19-vaccine-data-listed-and-available-to-request-through-hdr-innovation-gateway/?utm_source=hive&utm_medium=email
https://saildatabank.com/about-us/
https://www.ukri.org/news/octave-study-shows-real-world-vaccine-response-in-at-risk-patients/
Description:
OCTAVE is a multi-disease, observational, cohort trial that will seek to understand the immune response to SARS-CoV-2 vaccinations in patients with certain immunosuppressed conditions.
Cohorts will include patients with chronic renal conditions, chronic liver conditions, inflammatory bowel disease, cancer (both solid and haematological malignancies), immune-mediated rheumatic/inflammatory conditions and haematopoietic stem cell transplant (HSCT) and chimeric antigen receptor (CAR) T recipients. OCTAVE is a collaborative research project involving academic partners from the Universities of Glasgow, Birmingham, Oxford, Imperial College London and the IMPACT network. The project is funded by the Medical Research Council, and badged as an Urgent Public Health trial supported by the NIHR Clinical Research Network.
Coverage
Spatial:
United Kingdom
Typical Age Range:
0-120
Follow Up:
Other
Pathway:
Covid-19, Cohorts will include patients with chronic renal conditions, chronic
liver conditions, inflammatory bowel disease, cancer (both solid and
haematological malignancies), immune-mediated rheumatic/inflammatory conditions
and haematopoietic stem cell transplant (HSCT) and chimeric antigen receptor
(CAR) T recipients.
Provenance
Origin
Sources:
Other
Collection Situations:
- Other
- Secondary care - In-patients
Temporal
Accrual Periodicity:
Daily
Start Date:
01 January 2023
Time Lag:
Less than 1 week
Accessibility
Access
Access Service:
The SAIL Databank is powered by the UK Secure e-Research Platform (UKSeRP).
Following approval through safeguard processes, access to project-specific data
within the secure environment is permitted using two-factor authentication.
Access Request Cost:
Data provision is free from SAIL. Overall project costing depends on the number
of people that require access to the SAIL Gateway, the activities that SAIL
needs to complete (e.g. loading non-standard datasets), data refreshes,
analytical work required, disclosure control process, and special case
technological requirements.
Delivery Lead Time:
Not applicable
Jurisdictions:
GB-GBN
Data Controller:
SAIL Databank
Data Processor:
SAIL Databank
Usage
Data Use Limitations:
Research-specific restrictions
Data Use Requirements:
- Project-specific restrictions
- User-specific restriction
Resource Creators:
Digital Health and Care Wales (DHCW)
Format and Standards
Vocabulary Encoding Schemes:
LOCAL
Languages:
en
Formats:
SQL database table
Observations
Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Persons
Patients with immunocompromised or immunosuppressed conditions.
5000
Count
29 September 2021